Literature DB >> 3769966

Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis.

G J Duffy, K Thirumurthi, M Casey, F Barker, N Brennan, C Odlum, M X Fitzgerald.   

Abstract

Gallium-67 (67Ga) lung scanning has been applied for some years in pulmonary sarcoidosis to assess the activity of the alveolitis. Interpreting the scans, however, is difficult due to the low uptake of 67Ga in the disease process relative to background activity. In this study we have measured the mean parenchymal lung activity of 67Ga and have compared the lung activity to that at three remote sites, the liver, the abdomen and the thigh. The results obtained were compared with the percentage of lymphocytes in broncho-alveolar lavage fluid. There was a very good correlation with the lung-to-thigh uptake measurements and a much poorer correlation with the lung-to-liver and the lung-to-abdomen measurements. It was observed that steroid therapy reduced dramatically the correlation between the broncho-alveolar lavage findings and the 67Ga scan measurements. The results suggest that in patients not on steroid therapy, the 67Ga lung-to-thigh measurements may be used, similarly to the broncho-alveolar lavage lymphocyte counts, to identify those with high-intensity alveolitis from those with low-intensity alveolitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3769966     DOI: 10.1007/bf00256919

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Gallium 67 citrate scanning in patients with pulmonary sarcoidosis.

Authors:  A Heshiki; S L Schatz; K A McKusick; D W Bowersox; J S Soin; H N Wagner
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-12

2.  Management of pulmonary sarcoidosis.

Authors: 
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

3.  The present status of treatment of pulmonary sarcoidosis: a house divided.

Authors:  R A DeRemee
Journal:  Chest       Date:  1977-03       Impact factor: 9.410

4.  67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis.

Authors:  C Alberts; J B van der Schoot; A S Groen
Journal:  Eur J Nucl Med       Date:  1981

5.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

6.  Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy.

Authors:  R P Baughman; M Fernandez; C H Bosken; J Mantil; P Hurtubise
Journal:  Am Rev Respir Dis       Date:  1984-05

7.  Computer-assisted versus visual lung gallium-67 index in normal subjects and in patients with interstitial lung disorders.

Authors:  L J Wesselius; K F Witztum; A T Taylor; M T Hartman; K M Moser
Journal:  Am Rev Respir Dis       Date:  1983-12

8.  Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis.

Authors:  C I Schoenberger; B R Line; B A Keogh; G W Hunninghake; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

9.  The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function.

Authors:  B A Keogh; G W Hunninghake; B R Line; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-08

Review 10.  NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.

Authors: 
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

View more
  5 in total

1.  Thoracic imaging with gallium-67.

Authors:  H Klech; H Köhn; M Huppmann; W Pohl
Journal:  Eur J Nucl Med       Date:  1987

2.  Pulmonary alveolar proteinosis: primary and secondary, a report of three cases.

Authors:  D M Gilligan; M M McCabe; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1989-01       Impact factor: 1.568

3.  Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis.

Authors:  M Myslivecek; V Husák; V Kolek; M Budíková; P Koranda
Journal:  Eur J Nucl Med       Date:  1992

4.  Imaging of pulmonary disease in scleroderma with J001X scintigraphy.

Authors:  P Diot; E Diot; E Lemarie; J L Guilmot; J L Baulieu; E Asquier; C Valat; A Delarue; A Le Pape
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

5.  Gallium-67 citrate imaging for the assessment of radiation pneumonitis.

Authors:  M Kataoka
Journal:  Ann Nucl Med       Date:  1989-07       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.